These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9764610)

  • 1. Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.
    Di Bona D; Montalto G; Clemenza L; Bascone F; Accardo P; Bellavia D; Craxì A; Brai M
    Clin Exp Immunol; 1998 Oct; 114(1):102-5. PubMed ID: 9764610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of soluble complement receptor 1 in serum patients with liver diseases.
    Sadallah S; Giostra E; Mentha G; Schifferli JA
    Hepatology; 1996 Jul; 24(1):118-22. PubMed ID: 8707249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
    Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
    J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The changes and significance of red cell nature-immune-adhesion function in liver diseases at different stages].
    Wang HB; Zhang JW; Guo JX; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):455-8. PubMed ID: 12887755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble complement receptor type 1 (CD35) in bronchoalveolar lavage of inflammatory lung diseases.
    Hamacher J; Sadallah S; Schifferli JA; Villard J; Nicod LP
    Eur Respir J; 1998 Jan; 11(1):112-9. PubMed ID: 9543279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of plasma soluble complement receptor type 1 in patients receiving thrombolytic therapy for acute myocardial infarction.
    Karthikeyan G; Baalasubramanian S; Seth S; Das N
    J Thromb Thrombolysis; 2007 Apr; 23(2):115-20. PubMed ID: 17131173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble complement receptor type 1 in serum and cerebrospinal fluid of patients with Guillain-Barré syndrome and multiple sclerosis.
    Vedeler CA; Matre R; Sadallah S; Schifferli J
    J Neuroimmunol; 1996 Jun; 67(1):17-20. PubMed ID: 8707926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble complement receptor type 1 (CD35) is released from leukocytes by surface cleavage.
    Danielsson C; Pascual M; French L; Steiger G; Schifferli JA
    Eur J Immunol; 1994 Nov; 24(11):2725-31. PubMed ID: 7957565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of plasma soluble complement receptor 1 (sCR1) in normal Indian adult population.
    Sivasankar B; Raju KR; Anand V; Malu S; Padmanabhan S; Tiwari SC; Das N; Srivastava LM
    Indian J Clin Biochem; 1999 Jul; 14(2):237-40. PubMed ID: 23105224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A soluble deletion mutant of the human complement receptor type 1, which lacks the C4b binding site, is a selective inhibitor of the alternative complement pathway.
    Scesney SM; Makrides SC; Gosselin ML; Ford PJ; Andrews BM; Hayman EG; Marsh HC
    Eur J Immunol; 1996 Aug; 26(8):1729-35. PubMed ID: 8765013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of circulating immune complexes by complement receptor type 1 on erythrocytes in chronic viral liver diseases.
    Miyaike J; Iwasaki Y; Takahashi A; Shimomura H; Taniguchi H; Koide N; Matsuura K; Ogura T; Tobe K; Tsuji T
    Gut; 2002 Oct; 51(4):591-6. PubMed ID: 12235086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury.
    Mulligan MS; Yeh CG; Rudolph AR; Ward PA
    J Immunol; 1992 Mar; 148(5):1479-85. PubMed ID: 1311349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of complement inhibition with soluble complement receptor 1 on pig allotransplant lung function.
    Pierre AF; Xavier AM; Liu M; Cassivi SD; Lindsay TF; Marsh HC; Slutsky AS; Keshavjee SH
    Transplantation; 1998 Sep; 66(6):723-32. PubMed ID: 9771835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
    Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternatively spliced tissue factor levels are elevated in the plasma of patients with chronic liver diseases.
    Caversaccio NI; Reina Caro MD; Prince R; Müller M; Lewis CS; Bogdanov VY; Dufour JF; Angelillo-Scherrer A
    Eur J Gastroenterol Hepatol; 2018 Dec; 30(12):1470-1475. PubMed ID: 30113368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia.
    Lehmann TG; Koeppel TA; Münch S; Heger M; Kirschfink M; Klar E; Post S
    Microvasc Res; 2001 Nov; 62(3):284-92. PubMed ID: 11678631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroprotective effects of the SCR1-3 functional domain of CR1 on acute cerebral ischemia and reperfusion injury in rats.
    Yang S; Wang X; Zhang X; Lu Y; Wang Z
    Neurol Res; 2013 Nov; 35(9):976-83. PubMed ID: 23815859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes.
    Pascual M; Steiger G; Sadallah S; Paccaud JP; Carpentier JL; James R; Schifferli JA
    J Exp Med; 1994 Mar; 179(3):889-99. PubMed ID: 8113681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of evaluation of serum zinc concentrations in C-viral chronic liver disease.
    Moriyama M; Matsumura H; Fukushima A; Ohkido K; Arakawa Y; Nirei K; Yamagami H; Kaneko M; Tanaka N; Arakawa Y
    Dig Dis Sci; 2006 Nov; 51(11):1967-77. PubMed ID: 17048113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.